TRIFLUENT Trademark

Trademark Overview

On Friday, March 31, 2023, a trademark application was filed for TRIFLUENT with the United States Patent and Trademark Office. The USPTO has given the TRIFLUENT trademark a serial number of 97867082. The federal status of this trademark filing is ABANDONED - EXPRESS as of Thursday, August 28, 2025. This trademark is owned by Real Value Products Corporation. The TRIFLUENT trademark is filed in the Pharmaceutical Products category with the following description:

Prescription-only dermatological pharmaceutical products; Pain relief medication
trifluent

General Information

Serial Number97867082
Word MarkTRIFLUENT
Filing DateFriday, March 31, 2023
Status601 - ABANDONED - EXPRESS
Status DateThursday, August 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPrescription-only dermatological pharmaceutical products; Pain relief medication

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 26, 2023
Primary Code005
First Use Anywhere DateTuesday, September 1, 2020
First Use In Commerce DateTuesday, September 1, 2020

Trademark Owner History

Party NameReal Value Products Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78218

Trademark Events

Event DateEvent Description
Wednesday, December 27, 2023ASSIGNED TO EXAMINER
Tuesday, April 4, 2023NEW APPLICATION ENTERED
Wednesday, April 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 29, 2023NON-FINAL ACTION WRITTEN
Friday, December 29, 2023NON-FINAL ACTION E-MAILED
Friday, December 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 25, 2024LETTER OF SUSPENSION E-MAILED
Thursday, April 25, 2024SUSPENSION LETTER WRITTEN
Thursday, April 25, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 26, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, May 24, 2024SUSPENSION LETTER WRITTEN
Friday, May 24, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 24, 2024LETTER OF SUSPENSION E-MAILED
Friday, August 1, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, August 27, 2025TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, August 28, 2025ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Thursday, August 28, 2025ABANDONMENT - EXPRESS MAILED
Friday, January 31, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Related Keywords

trifluent pain relief medication products pharmaceutical only dermatological prescription